Chembio Diagnostics Inc (CEMI.OQ)
CEMI.OQ on NASDAQ Stock Exchange Capital Market
6.31USD
7 Dec 2018
6.31USD
7 Dec 2018
Change (% chg)
$0.00 (+0.00%)
$0.00 (+0.00%)
Prev Close
$6.31
$6.31
Open
$6.63
$6.63
Day's High
$6.65
$6.65
Day's Low
$6.31
$6.31
Volume
5,242
5,242
Avg. Vol
14,410
14,410
52-wk High
$11.55
$11.55
52-wk Low
$5.73
$5.73
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Sep '18 | 9.38 | -0.163 |
| Jun '18 | 8.72 | -0.122 | |
| Mar '18 | 7.72 | -0.049 | |
| FY 2017 | Dec '17 | 5.99 | -0.162 |
| Sep '17 | 7.59 | -0.047 | |
| Jun '17 | 4.11 | -0.177 | |
| Mar '17 | 6.33 | -0.132 | |
| FY 2016 | Dec '16 | 4.25 | -0.212 |
| Sep '16 | 3.75 | -0.192 | |
| Jun '16 | 3.27 | -0.863 | |
| Mar '16 | 6.60 | -0.032 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Dec-18 | 2 | 7.40 | 7.70 | 7.10 | 8.19 |
| Quarter Ending Mar-19 | 2 | 9.60 | 10.20 | 9.01 | -- |
| Year Ending Dec-18 | 2 | 32.90 | 33.50 | 32.29 | 29.60 |
| Year Ending Dec-19 | 2 | 39.76 | 41.02 | 38.50 | 34.86 |
| Earnings (per share) | |||||
| Quarter Ending Dec-18 | 2 | -0.13 | -0.08 | -0.18 | 0.01 |
| Quarter Ending Mar-19 | 2 | -0.09 | -0.05 | -0.14 | -- |
| Year Ending Dec-18 | 2 | -0.50 | -0.42 | -0.57 | -0.14 |
| Year Ending Dec-19 | 2 | -0.22 | -0.08 | -0.36 | 0.07 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 31.13 | 33.63 | |
| P/E High - Last 5 Yrs. | 60.44 | 40.59 | 45.43 | |
| P/E Low - Last 5 Yrs. | 43.00 | 23.99 | 24.43 | |
| Beta | 1.19 | 0.91 | 0.90 | |
| Price to Sales (TTM) | 4.21 | 4.00 | 5.77 | |
| Price to Book (MRQ) | 5.03 | 5.02 | 5.12 | |
| Price to Tangible Book (MRQ) | 6.34 | 5.76 | 6.54 | |
| Price to Cash Flow (TTM) | -- | 23.20 | 23.57 | |
| % Owned Institutions | 31.32 | 0.95 | 1.83 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 1.55 | 1.49 | |
| Dividend Yield - 5 Year Avg | -- | 1.56 | 1.50 | |
| Dividend 5 Year Growth Rate | -- | 4.21 | 5.08 | |
| Payout Ratio(TTM) | -- | 45.68 | 43.75 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 25.97 | 2.33 | 7.43 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -12.91 | 4.80 | 5.80 | |
| Sales - 5 Yr. Growth Rate | -1.62 | 10.00 | 10.19 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 79.54 | 17.26 | 21.03 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 29.28 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 9.88 | 10.79 | |
| Capital Spending - 5 Yr. Growth Rate | -30.40 | 15.23 | 15.12 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | 2.37 | 2.20 | 2.28 |
| Current Ratio (MRQ) | 3.66 | 3.02 | 3.11 |
| LT Debt to Equity (MRQ) | 0.00 | 8.89 | 11.47 |
| Total Debt to Equity (MRQ) | 0.00 | 12.69 | 15.63 |
| Interest Coverage (TTM) | -- | 35.18 | 31.38 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | 47.30 | 54.41 | 54.21 | |
| Gross Margin - 5 Yr. Avg. | 42.30 | 51.86 | 51.98 | |
| EBITD Margin (TTM) | -39.01 | -- | -- | |
| EBITD - 5 Yr. Avg | -4.67 | 18.41 | 11.83 | |
| Operating Margin (TTM) | -46.24 | 14.43 | 4.90 | |
| Operating Margin - 5 Yr. Avg. | -8.18 | 14.55 | 7.44 | |
| Pre-Tax Margin (TTM) | -46.01 | 14.96 | 5.91 | |
| Pre-Tax Margin - 5 Yr. Avg. | -8.15 | 14.97 | 7.89 | |
| Net Profit Margin (TTM) | -46.01 | 11.16 | 2.16 | |
| Net Profit Margin - 5 Yr. Avg. | -12.33 | 11.23 | 4.12 | |
| Effective Tax Rate (TTM) | -- | 23.45 | 23.36 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 23.65 | 24.15 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 140,773 | 997,016,926 | 898,926,015 | |
| Net Income/Employee (TTM) | -64,768 | 118,233,033 | 106,550,787 | |
| Receivable Turnover (TTM) | 3.99 | 5.82 | 5.94 | |
| Inventory Turnover (TTM) | 2.29 | 2.68 | 3.62 | |
| Asset Turnover (TTM) | 1.14 | 0.99 | 0.97 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -52.56 | 11.98 | 11.50 | |
| Return on Assets - 5 Yr. Avg. | -14.58 | 13.28 | 12.67 | |
| Return on Investment (TTM) | -68.16 | 15.55 | 15.02 | |
| Return on Investment - 5 Yr. Avg. | -17.83 | 17.28 | 16.45 | |
| Return on Equity (TTM) | -69.09 | 16.92 | 16.60 | |
| Return on Equity - 5 Yr. Avg. | -17.86 | 18.21 | 17.56 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -26.33 | -15.44 | -1.62 |
| EPS (TTM) % | -404.58 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Chembio Diagnostics Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | 5.00 | 1.38 | 65 | 20 |
| 13 Week | -0.79 | -5.62 | 52 | 34 |
| 26 Week | 15.60 | 6.81 | 76 | 28 |
| 52 Week | -13.10 | -26.35 | 34 | 12 |
| YTD | -7.35 | -18.64 | 34 | 25 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 40.68% |
| # of Holders: | 42 |
| Total Shares Held: | 6,992,184 |
| 3 Mo. Net Change: | 468,115 |
| # New Positions: | 5 |
| # Closed Positions: | 3 |
| # Increased Positions: | 20 |
| # Reduced Positions: | 8 |
| # Net Buyers: | 12 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.